Cargando…
Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a modest but significant increase in serum magnesium levels. This report describes improvement in serum magnesium and associated symptoms after initiating SGLT2i therapy in a patient with refractory hypomagnesemia. A 58-year-old...
Autores principales: | Saha, Arunava, Omer, Abdulkadir, Trivedi, Nitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578385/ https://www.ncbi.nlm.nih.gov/pubmed/37908255 http://dx.doi.org/10.1210/jcemcr/luac018 |
Ejemplares similares
-
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020) -
Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases
por: Shah, Chintan V., et al.
Publicado: (2022) -
Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
por: Konta, Yusuke, et al.
Publicado: (2022) -
Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium–glucose cotransporter 2 inhibitors
por: Ullah, Saad, et al.
Publicado: (2016) -
Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report
por: Nakamura, Miho, et al.
Publicado: (2020)